We showed that HOXA9, INSR, KRIT1, MYB, SPRY2, WEE1 and ZNF711 were up-regulated while UBE2V1 was down-regulated in AML patients (Figure 4A). Here, SPRY2 is linked to acute myeloid leukemia.